Rosan Vegter
16 January 2018

Five reasons not to miss EMA’s Awareness Sessions, this March

Academic researcher and drug developers can sometimes feel isolated and experience difficulties to find their way through the regulatory jungle. Once you solve one issue, another challenge presents itself. It can be tricky to know where to turn to find the right regulatory resources, insight or expertise to move your project forward.

That is why the European Medicines Agency (EMA) is organizing a second edition of the successful international awareness day for regulators, academia and non-governmental organizations at EMA’s premises in London on March 8-9th 2018.

It’s set to be a one-stop-shop where you can enrich your understanding of how the EMA can help you.

Here are the top 5 reasons to attend the EMA’s Awareness sessions in March;

1.  Discover everything you need to know about the regulatory landscape and EMA

You will be introduced to the EU Regulatory Network and the European Medicines Agency. You will get insight into the role of the EMA and discover the scientific nature of the agency’s work.

 

2.  Understand how to navigate the regulatory maze

The EMA has a wide range of support dedicated to (academic) research, such as the EMA Scientific Advice and the Innovation Task force, while PRIME will support academics pursuing unmet medical needs. Early assessment of the potential product requirements may prevent unnecessary project delays, reduce extra costs and most importantly, prevent penalties resulting from non-adherence to legal requirements.

 

3.  Learn from the experts

You will learn how to deal with different types of medicinal products (advanced therapeutics, pediatric and orphan medicines) and their approvals. Experts will tell you more about clinical trials, patient safety and how to deal with special population. Furthermore, you will learn more about benefit-risk evaluation, Health Technology assessment and reimbursement.

 

4.  Boost your network

By attending the EMA Awareness Days you can connect with a wide variety of stakeholders during the day and engage with patients, Health Care Professionals and pharmaceutical industry representatives during the evening Networking events.

 

5.  Broaden your global perspective

Enhancing international cooperation is part of EMA’s public health mission. You will learn how the agency continues to strengthen its collaboration with international partners, to ensure that medicines tested and manufactured outside the EU meet the EU requirements.

 

Register

Exited to learn more? Please register to the event by sending an email to EMAinternational@ema.europa.eu. Places are limited so early expression of interest is recommended and should be sent by 16 February 2018 to EMA

Please visit the link for further information and to vision the draft programme.

 

 

 

 

Website by Lewis+Humphreys